佰仁医疗
(688198)
| 流通市值：151.00亿 | | | 总市值：151.00亿 |
| 流通股本：1.37亿 | | | 总股本：1.37亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 100,209,729.99 | 56,009,752.25 | 140,466,045.93 | 168,438,197.57 |
| 应收票据及应收账款 | 129,276,028.99 | 133,436,510.87 | 103,895,915.4 | 94,845,403.99 |
| 其中：应收票据 | 6,168,097.44 | 11,880,000.34 | 9,726,647.42 | 6,468,218.45 |
| 应收账款 | 123,107,931.55 | 121,556,510.53 | 94,169,267.98 | 88,377,185.54 |
| 预付款项 | 26,823,236.61 | 26,476,278.35 | 15,196,495.86 | 18,696,430.03 |
| 其他应收款合计 | 18,321,858.07 | 4,770,179.98 | 6,919,132.42 | 5,389,639.64 |
| 其中:应收利息 | 3,428,936.98 | 3,428,936.98 | 3,244,499.45 | 3,357,342.73 |
| 存货 | 62,935,876.44 | 52,741,145.76 | 51,031,455.13 | 41,366,575.08 |
| 一年内到期的非流动资产 | 136,847,041.08 | 135,869,369.84 | 135,897,402.59 | 6,151,666 |
| 其他流动资产 | 15,515,911.19 | 3,340,713.46 | 26,305,046.68 | 10,674,034.08 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 627,974,165.38 | 590,807,691.95 | 592,585,292.75 | 481,905,651.51 |
| 非流动资产: | | | | |
| 固定资产 | 337,025,622.85 | 336,067,909.45 | 102,260,655.65 | 82,709,996.31 |
| 在建工程 | 87,944,083.77 | 87,667,406.29 | 266,236,049.21 | 220,478,694.63 |
| 使用权资产 | 14,845,300.32 | 10,002,893.65 | 10,873,950.98 | 11,548,324.14 |
| 无形资产 | 112,184,029.53 | 112,182,525.15 | 111,781,916.92 | 114,350,551.82 |
| 商誉 | 17,244,139.9 | 17,268,643.29 | 16,833,828.25 | 17,120,662.04 |
| 长期待摊费用 | 17,671,876.97 | 18,878,428.97 | 530,581.46 | 663,226.73 |
| 递延所得税资产 | 15,495,605.1 | 14,812,474.14 | 13,371,810.45 | 22,323,368.87 |
| 其他非流动资产 | 242,937,804.96 | 243,159,784.92 | 167,675,687.05 | 312,201,396.57 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 845,348,463.4 | 840,040,065.86 | 689,564,479.97 | 781,396,221.11 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,473,322,628.78 | 1,430,847,757.81 | 1,282,149,772.72 | 1,263,301,872.62 |
| 流动负债: | | | | |
| 短期借款 | 25,000,000 | - | - | - |
| 应付票据及应付账款 | 54,440,177.5 | 66,464,107.44 | 38,116,279.52 | 46,682,741.08 |
| 应付账款 | 54,440,177.5 | 66,464,107.44 | 38,116,279.52 | 46,682,741.08 |
| 合同负债 | 3,025,203.83 | 1,320,433.24 | 532,562.77 | 363,564.11 |
| 应付职工薪酬 | 12,025,318.21 | 20,512,218.94 | 15,751,624.25 | 13,263,624.39 |
| 应交税费 | 9,510,267.77 | 12,843,462.66 | 2,271,003.61 | 3,227,299.99 |
| 其他应付款合计 | 8,232,965.79 | 9,655,657.57 | 5,813,546.2 | 17,360,903.82 |
| 一年内到期的非流动负债 | 3,484,243.53 | 3,451,932.22 | 3,380,197.35 | 3,468,734.91 |
| 其他流动负债 | 393,276.49 | 37,035.25 | 15,976.9 | 10,906.93 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 116,111,453.12 | 114,284,847.32 | 65,881,190.6 | 84,377,775.23 |
| 非流动负债: | | | | |
| 租赁负债 | 11,078,238.54 | 6,333,110.65 | 7,351,897.44 | 7,984,525.26 |
| 长期应付款 | 180,000 | 1,080,000 | 4,529.43 | 17,842.85 |
| 预计负债 | 15,233,907.26 | 12,332,070.54 | 1,675,182.94 | 1,404,659.22 |
| 递延收益 | 34,559,165.25 | 33,234,022.33 | 32,878,114.72 | 33,132,028.71 |
| 递延所得税负债 | 13,384,812.95 | 13,013,286.23 | 11,090,230.73 | 11,603,520.5 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 74,436,124 | 65,992,489.75 | 52,999,955.26 | 54,142,576.54 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 190,547,577.12 | 180,277,337.07 | 118,881,145.86 | 138,520,351.77 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 137,395,148 | 137,395,148 | 137,395,148 | 136,579,240 |
| 资本公积 | 825,110,193.16 | 833,694,157.84 | 830,647,166.73 | 814,372,865.92 |
| 其他综合收益 | 1,646,117.03 | 1,679,067.5 | 1,061,906.75 | 1,621,111.51 |
| 盈余公积 | 64,219,151.63 | 64,219,151.63 | 45,299,603.12 | 45,299,603.12 |
| 未分配利润 | 258,754,286.16 | 226,249,967.99 | 157,532,731.02 | 134,030,062.38 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,287,124,895.98 | 1,263,237,492.96 | 1,171,936,555.62 | 1,131,902,882.93 |
| 少数股东权益 | -4,349,844.32 | -12,667,072.22 | -8,667,928.76 | -7,121,362.08 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,282,775,051.66 | 1,250,570,420.74 | 1,163,268,626.86 | 1,124,781,520.85 |
| 负债和股东权益合计 | 1,473,322,628.78 | 1,430,847,757.81 | 1,282,149,772.72 | 1,263,301,872.62 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-30 | 2024-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |